This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations.(February 2013) (Learn how and when to remove this message)
This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. Find sources: "Charles Weissmann" – news · newspapers · books · scholar · JSTOR(April 2015) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Charles Weissmann
Weissmann in 1982
Born
(1931-10-14) 14 October 1931 (age 92)
Alma mater
University of Zurich
Charles Weissmann (born 14 October 1931) is a Hungarian-Swiss molecular biologist. Weissmann is particularly known for the first cloning and expression of interferon and his contributions to the unraveling of the molecular genetics of neurogenerative prion diseases such as scrapie, Creutzfeldt–Jakob disease and "mad cow disease".
Weissmann went to University of Zurich and obtained his MD in 1956 and Ph.D. in Organic Chemistry in 1961. In 1978, Weissmann co-founded the biotech company Biogen in Geneva. Biogen is considered one of the pioneers of the biotechnology industries. Weissmann was director of the Institute for Molecular Biology in Zurich, President of the Roche Research Foundation and co-founder and Member of the Scientific Council of Biogen. He was Chairman of the Department of Infectology, Scripps Florida until 2011.
Weissmann won several awards, including the Otto Warburg Medal (1980) and the Scheele Award (1982). A member of the American Society of Biological Chemistry and the Deutsche Akademie der Naturforscher Leopoldina he is also a Foreign Associate of the U.S. National Academy of Sciences, the Royal Society (UK) and the Pour le Mérite (Germany). On 16 May 2011 Weissmann became Doctor of Science Honoris Causa at New York University.
CharlesWeissmann (born 14 October 1931) is a Hungarian-Swiss molecular biologist. Weissmann is particularly known for the first cloning and expression...
biologist, evolutionary theorist and proposer of the Weismann barrier CharlesWeissmann (born 1931), Hungarian-Swiss molecular biologist Drew Weissman (born...
Schaller from the University of Heidelberg, and CharlesWeissmann from the University of Zurich (Weissmann contributed the first product interferon alpha)...
Ernst, Edzard (2022). Charles, the alternative prince an unauthorised biography. Imprint Academic. ISBN 978-1-78836-070-8.; Weissmann, Gerald (September...
Ulrich Aldag, Freimut Leidenberger, Heinrich Schulte, Rudolf Rigler, CharlesWeissmann and Nobel Laureate Manfred Eigen. Eigen won the 1967 Nobel Prize in...
Roush, Paul Schimmel, Peter G. Schultz, Gary Siuzdak, Eric Topol, CharlesWeissmann, Ian Wilson, Peter Wright, Chi-Huey Wong and John R. Yates. In addition...
critic Sigismond Thalberg, pianist and composer Regina Ullmann, poet CharlesWeissmann, biochemist Alain and Gérard Wertheimer, owners of Chanel John Bercow...
Project David Schwarz, inventor of the Zeppelin[full citation needed] CharlesWeissmann, biochemist Eugene Wigner (Wigner Jenő), physicist and Nobel laureate...
Rogerson Awards Preceded by Noreen Murray Gabor Medal 1991 Succeeded by CharlesWeissmann Preceded by Jean-Marie Lehn Davy Medal 1998 Succeeded by Malcolm H...
Gilbert who was beginning to found Biogen Inc. along with Phil Sharp, CharlesWeissmann, and Kenneth Murray. During her sabbatical after eight years at Harvard...
Archived from the original on January 6, 2005. Retrieved December 26, 2016. Weissmann, Shoshana (May 10, 2016). "Sykes: If You Embrace Trump, You Embrace Every...
1998 Heiner Ryssel, 1998 Klaus Pinkau, 1997 Hans A. Leopold, 1997 CharlesWeissmann, 1997 Ingeborg Hochmair-Desoyer, 1996 Herbert Mang, 1996 Heinrich...
Otto Westphal [de] (Switzerland) 1994 Paul Klein [de] (Germany) 1995 CharlesWeissmann (Switzerland) 1996 Sir Gustav Nossal (Australia) 1997 Satoshi Ōmura...
Peter Richardson and Karl Julius Ullrich [de] 1988: Helmut Sies and CharlesWeissmann 1989: Thomas F. Budinger [de] and Jon van Rood 1990: Gerhard Giebisch...
Mühlethaler and Hans J. Moor 1968: Michel Dolivo 1969: Walter Heitler 1970: CharlesWeissmann 1971: Manfred Bleuler 1972: Albert Eschenmoser 1973: Lucien Girardier...
Speiser [Wikidata] 1980 Harri R. Nevanlinna [fi] 1981 George Aghajanian 1982 CharlesWeissmann 1983 James W. Black 1984 Malcolm Rowland 1985 Stanley S. Davis 1986...
Robert Wood Johnson Medical School, David Goeddel, Tularik, Inc., and CharlesWeissmann, Imperial College School of Medicine, London For purification and...
2000 James Watson 1999 Eric F. Wieschaus 1998 David Hopwood 1998 CharlesWeissmann 1997 Elliot Meyerowitz 1994 Seymour Benzer 1992 Christiane Nüsslein-Volhard...
for The New York Times Patrick Desbois, President, Yahad-In Unum CharlesWeissmann, Professor and Chairman, Department of Infectology, The Scripps Research...
Rudolf Kelterborn, musician and composer (died 2021) 4 October – CharlesWeissmann, Hungarian-Swiss molecular biologist 10 October – Bruno Weber, artist...
1977 Francis Crick 1976 No award 1975 Heinz-Gunter Wittmann 1974 CharlesWeissmann 1973 Arthur B. Pardee 1972 Ephraim Katchalski 1971 David Chilton Phillips...
UCL Institute of Neurology in 2002 to work with John Collinge and CharlesWeissmann on prion cell biology. She was promoted to UCL Clinical Senior Lecturer...
Dunston Max Lord Melvin Charles Bradford Marshall Mathers Andre Young Lord Bennett 2:31 9. "Doomsday Pt. 2" (with Eminem) Weissmann Bennett Nocito Mathers...
1988 Thomas R. Cech 1985 Bela Julesz and Werner E. Reichardt 1982 CharlesWeissmann 1979 Aaron Klug 1976 Laurens L. M. van Deenen 1973 Christian de Duve...
received his doctorate in molecular biology under the supervision of CharlesWeissmann. The same year he started working at the Cancer Institute, Japanese...